HYBRID EVENT: You can participate in person at Valencia, Spain or Virtually from your home or work.
Impact of Covid-19 on Pharmaceutical Industry
As economies all around the world are suffering from the impact of Covid-19, businesses are experiencing losses, workers are without jobs, and many face the challenge of a complete upheaval of lifestyle. However, pharmaceutical companies taking centre stage in the Covid-19 fight and a new innovation in the infectious disease landscape as the race for treatment approval for a Covid-19 therapy takes off.
Pharmaceutical companies are on the line and their impact on the fight against the virus will not be easily forgotten. The concept of large profits coming from newly developed drugs will increased consider in a time of global pandemic as a result of public and competitive pressures.
Committee Members
Saad Tayyab
UCSI University, Malaysia
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Marino Nebuloni
University of Insubria, Italy PDDS 2025 Speakers
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Marino Nebuloni
University of Insubria, Italy
Saad Tayyab
UCSI University, MalaysiaSubmit your abstract Today
Title : Medical liver Biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Macitentan/Tadalafil Combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia